2014
DOI: 10.1016/j.cellimm.2014.08.003
|View full text |Cite
|
Sign up to set email alerts
|

Soluble CD83 inhibits human monocyte differentiation into dendritic cells in vitro

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
16
0

Year Published

2015
2015
2020
2020

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 19 publications
(16 citation statements)
references
References 30 publications
0
16
0
Order By: Relevance
“…sCD83 is a potent inhibitor of anti-CD3-induced proliferation of T cells and production of IL-2 and IFN-␥ by PBMCs, but the molecular mechanism by which CD83 suppresses the immune system is not understood (52)(53)(54). Virus-mediated suppression of CD83 expression reduces the stimulatory capacity of human DCs (55).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…sCD83 is a potent inhibitor of anti-CD3-induced proliferation of T cells and production of IL-2 and IFN-␥ by PBMCs, but the molecular mechanism by which CD83 suppresses the immune system is not understood (52)(53)(54). Virus-mediated suppression of CD83 expression reduces the stimulatory capacity of human DCs (55).…”
Section: Discussionmentioning
confidence: 99%
“…Sandwich ELISA. sCD83 levels were determined using a sandwich ELISA (36,39,55,68). Ninety-sixwell plates were precoated with a polyclonal rabbit antibody to the CD83 C terminus (3 g/ml; Abcam, Cambridge, United Kingdom) at 4°C overnight and then blocked with 10% nonfat dry milk in phosphatebuffered saline (PBS) prior to sample application.…”
Section: Methodsmentioning
confidence: 99%
“…Recently, the soluble CD83 (sCD83) molecule has been demonstrated to exert strong anti-inflammatory reactions and can act as an immuno-suppressive mediator to regulate the activation and maturation of dendritic cells (DCs) and monocytes 20 , 21 . Moreover, it has been reported to be a potential therapeutic agent for use in the treatment of autoimmune diseases 21 25 .…”
Section: Introductionmentioning
confidence: 99%
“…In turn, mCD83 is hydrolyzed by enzymes to product sCD83, which is secreted to regulate the maturation of NK cells. Elevated sCD83 binds with myeloid differentiation factor-2 (MD-2) to alter the TLR-4 signaling pathway to regulate the function of CD14+ monocytes 28 and reduces expression levels of CD1a, CD80, CD86 and MHC II to inhibit monocyte differentiation into DCs 20 . sCD83 can also induce tolerogenic DCs and reduce the expressions of CD40, CD80 and CD83 on DCs, and, in this way, alter the maturation of DCs 21 , 22 , 27 .…”
Section: Introductionmentioning
confidence: 99%
“…In contrast, sCD83 functions as a suppressor of T cell activation [ 11 ]. A recent study has shown that sCD83 suppresses the differentiation of DCs from monocytes [ 12 ]. Elevated levels of plasma sCD83 have been demonstrated in patients with hematological malignancies [ 13 ].…”
Section: Introductionmentioning
confidence: 99%